BSIP-Bipolar: Better Sleep in Psychiatric Care - Bipolar

Sponsor
Karolinska Institutet (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04130529
Collaborator
Region Stockholm (Other)
85
2
2
53
42.5
0.8

Study Details

Study Description

Brief Summary

Cognitive Behavioral Therapy (CBT) is treatment of choice for insomnia. Many patients in psychiatric care have sleep problems including insomnia, but are rarely given the choice to participate in CBT to improve their sleep. Patients with Bipolar disorder is a patient group with high levels of sleep difficulties. Sleep problems in this patient group can be both more general such as insomnia, but can also be related to the Bipolar disorder. Other research groups have studied the use of behaviorally sleep treatments in patients with Bipolar disorder, but more studies are needed. In a previous pilot study, the investigators of the current study developed a CBT protocol that would target sleep problems in this population. The basis was CBT for insomnia (CBT-i), but with more emphasis on achieving sleep promoting behaviors specific to Bipolar patients, for instance techniques that would also alleviate sleep phase problems, (e.g. the systematic use of light and darkness), and techniques to target more general sleep related problems (e.g. difficulties waking up in the morning), that are also common in patients with Bipolar disorder. This treatment was well tolerated and gave moderate effects on insomnia severity in the pilot study. In a naturalistic randomized controlled trial, the investigators now evaluate the effects of this psychological treatment on sleep and Bipolar symptoms in patients at the departments of Affective disorders, Northern Stockholm Psychiatry and Southwest Psychiatry, Stockholm, Sweden.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Adjusted group CBT-i for Bipolar disorder
  • Other: Sleep lectures
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
85 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Better Sleep in Psychiatric Care - Bipolar. A Randomized Naturalistic Study of a Psychological Group Treatment for Sleep Problems in Psychiatric Patients With Bipolar Disorder
Actual Study Start Date :
Oct 1, 2019
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Adjusted group CBT-i for Bipolar disorder

The experimental group receives group-CBT-i adjusted for Bipolar disorder. This is a version of CBT for insomnia (CBT-i) developed during the pilot phase of this Project. Traditional CBT-i is adjusted for use in the population with Bipolar Disorder. This behavioral intervention adresses not only traditional aspects of insomnia, but also sleep phase problems and other aspects of sleep specifically relevant to the Bipolar population. Treatment is given as 8 weekly group sessions.

Behavioral: Adjusted group CBT-i for Bipolar disorder
CBT-i includes sleep scheduling/sleep compression, stimulus control, relaxation, cognitive interventions and sleep hygiene advice. In addition components targeting circadian rhythm problems and problems with very high or very low levels of activity are included.

Active Comparator: Sleep lectures

The control group is offered a series of 3 lectures on sleep during the same time-period.

Other: Sleep lectures
Lectures on the topic of sleep.

Outcome Measures

Primary Outcome Measures

  1. Insomnia Severity Index (ISI) [Changes from base-line to 8 weeks, 5 months and 14 months]

    7-item, self-rated questionnaire measuring change in insomnia severity. Total score 0-28, higher score indicates more severe sleep problems.

Secondary Outcome Measures

  1. WHO Disability Assessment Schedule (WHODAS) [Changes from base-line to 8 weeks, 5 months and 14 months]

    12-items self-rating questionnaire measuring disability. Total score (0-48), with higher score indicating more severe disability.

  2. Affective Self Rating Scale (AS-18) [Changes from base-line to 8 weeks, 5 months and 14 months]

    18-items self-report questionnaire measuring bipolar symptoms. Total score 0-72, subscale for depression (0-36), subscale for mania (0-36). Higher score indicates more severe symptoms.

  3. Sleep habits and behaviors [Changes from base-line to 8 weeks, 5 months and 14 months]

    Self-rating questionnaire regarding the use of sleep promoting behaviors. The questionnaire was constructed for the larger BSIP project and consists of two parts. The first part includes statements such as "Last week I got out of bed within 15 minutes of waking up" to be answered by number of days the last week this was true (i.e. from 0 to 7). The other part is to be answered on a 6-point Likert scale from "Not at all true" to "Entirely true", with 7 statements like "I get out of bed the same time every morning". No total score is obtained.

  4. Daytime Insomnia Symptoms [Changes from base-line to 8 weeks, 5 months and 14 months]

    7-item self-rating questionnaire regarding daytime symptoms commonly associated with sleep problems. Total score 0-70, with higher score indicating more severe daytime symptoms.

  5. Actigraphy [Changes from base-line to post 8 weeks.]

    An actigraph is placed on the participant's arm for one week. It measures participants' arm-movements. An algorithm can be used to estimate sleep from movement data.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Being a patient at the clinics involved in the project

  • Experiencing sleep problems (subjective report)

  • Being able to participate in a psychological intervention in group format

Exclusion Criteria:
  • Night shift work

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Affective Disorders, Northern Stockholm Psychiatry Stockholm Sweden 11321
2 Department of Affective Disorders, Stockholm Southwest Psychiatry Stockholm Sweden 14186

Sponsors and Collaborators

  • Karolinska Institutet
  • Region Stockholm

Investigators

  • Principal Investigator: Susanna Jernelöv, PhD, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Susanna Jernelöv, Principal Investigator, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT04130529
Other Study ID Numbers:
  • 2018/80-31/1
First Posted:
Oct 17, 2019
Last Update Posted:
Mar 31, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Susanna Jernelöv, Principal Investigator, Karolinska Institutet
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2022